chr22:24819565:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr22:24,819,565-24,838,325 |
| hg38 | chr22:24,423,597-24,442,357 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
| <0.001 | Dementia, Vascular | NA | BeFree | Detail | |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| 0.122 | drug allergy | NA | CTD_human,GAD | Detail | |
| <0.001 | Dyskinetic syndrome | Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Park... | BeFree | 25872644 | Detail |
| <0.001 | epidermodysplasia verruciformis | NA | BeFree | Detail | |
| 0.002 | Fatigue | NA | GAD | Detail | |
| 0.003 | Fibrosis | NA | LHGDN | Detail | |
| <0.001 | Headache | NA | BeFree | Detail | |
| <0.001 | Heart failure | NA | BeFree | Detail | |
| <0.001 | congestive heart failure | NA | BeFree | Detail | |
| <0.001 | Hodgkin Disease | NA | BeFree | Detail | |
| 0.008 | Huntington disease | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Hypertensive disease | NA | BeFree,GAD | Detail | |
| 0.120 | Hypotension | NA | CTD_human | Detail | |
| 0.122 | Sleep Initiation and Maintenance Disorders | NA | CTD_human,GAD | Detail | |
| 0.003 | ischemia | NA | LHGDN | Detail | |
| <0.001 | Lesch-Nyhan syndrome | NA | BeFree | Detail | |
| 0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
| 0.080 | Lung diseases | NA | RGD | Detail | |
| 0.003 | Chronic Obstructive Airway Disease | NA | LHGDN | Detail | |
| <0.001 | myopia | NA | BeFree | Detail | |
| 0.134 | panic disorder | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.003 | Parkinson disease | Increased striatal adenosine A2A receptor levels is an early event in Parkinson'... | BeFree,GAD | 24892887 | Detail |
| 0.122 | Psychoses, Substance-Induced | NA | CTD_human,GAD | Detail | |
| 0.080 | Reperfusion Injury | NA | RGD | Detail | |
| 0.004 | schizophrenia | NA | BeFree,GAD | Detail | |
| <0.001 | systemic scleroderma | NA | BeFree | Detail | |
| 0.120 | Seizures | NA | BeFree,CTD_human | Detail | |
| <0.001 | status epilepticus | NA | BeFree | Detail | |
| 0.120 | Substance Withdrawal Syndrome | NA | CTD_human | Detail | |
| 0.005 | Syncope | NA | BeFree,GAD,LHGDN | Detail | |
| 0.120 | Tremor | NA | CTD_human | Detail | |
| 0.120 | Adverse reaction to drug | NA | CTD_human | Detail | |
| 0.002 | Weight Gain | NA | GAD | Detail | |
| <0.001 | essential hypertension | NA | BeFree | Detail | |
| <0.001 | Encephalopathies | NA | BeFree | Detail | |
| <0.001 | Migraine Disorders | NA | BeFree | Detail | |
| <0.001 | obstructive nephropathy | NA | BeFree | Detail | |
| <0.001 | lingual-facial-buccal dyskinesia | NA | BeFree | Detail | |
| <0.001 | migraine with aura | NA | BeFree | Detail | |
| <0.001 | Renal interstitial fibrosis | NA | BeFree | Detail | |
| 0.122 | Amphetamine-Related Disorders | NA | CTD_human,GAD | Detail | |
| <0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
| 0.120 | Ventricular Dysfunction | NA | CTD_human | Detail | |
| <0.001 | Carcinoma, Lewis Lung | NA | BeFree | Detail | |
| <0.001 | Chronic heart failure | The association of ADORA2A and ADORA2B polymorphisms with the risk and severity ... | BeFree | 25629231 | Detail |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | Phobic anxiety disorder | NA | BeFree | Detail | |
| <0.001 | Abnormal involuntary movement | NA | BeFree | Detail | |
| 0.120 | Hyperactive behavior | NA | CTD_human | Detail | |
| <0.001 | Neurodegenerative Disorders | Overall, these findings reveal that increased A2AR protein levels occur in asymp... | BeFree | 24892887 | Detail |
| 0.003 | Mood Disorders | NA | BeFree,GAD | Detail | |
| <0.001 | inflammatory joint disease | NA | BeFree | Detail | |
| <0.001 | Tardive Dyskinesia | NA | BeFree | Detail | |
| 0.002 | Chronic progressive chorea | NA | GAD | Detail | |
| 0.005 | Sleep Disorders | NA | GAD | Detail | |
| 0.120 | Cardiomyopathies | NA | CTD_human | Detail | |
| <0.001 | Sleeplessness | NA | BeFree | Detail | |
| <0.001 | Autism Spectrum Disorders | NA | BeFree | Detail | |
| 0.080 | MYOPIA 2 (disorder) | NA | MGD | Detail | |
| 0.002 | PANIC DISORDER 1 | NA | BeFree | Detail | |
| 0.002 | Weight Gain Adverse Event | NA | GAD | Detail | |
| 0.080 | Idiopathic pulmonary arterial hypertension | NA | MGD | Detail | |
| <0.001 | agoraphobia | NA | BeFree | Detail | |
| <0.001 | Alzheimer's disease | We found that humans with Alzheimer's disease (AD) had increased levels of the G... | BeFree | 25622143 | Detail |
| 0.125 | Anxiety Disorders | NA | BeFree,CTD_human,GAD | Detail | |
| 0.125 | rheumatoid arthritis | NA | BeFree,CTD_human,GAD | Detail | |
| 0.008 | asthma | NA | GAD,LHGDN | Detail | |
| 0.002 | atherosclerosis | NA | GAD | Detail | |
| 0.003 | autistic disorder | NA | BeFree,GAD | Detail |
Annotation
Annotations
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr22:24,819,565-24,838,325
- Variant Type
- snv
Genome browser